^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Clear Cell Renal Cell Carcinoma |
| Drug: | Inlyta (axitinib) (VEGFR inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
02/03/2021
Excerpt:
First-line therapy for clear cell histology: Useful in certain circumstances…Axitinib (category 2B).
